The safety of subcutaneously administered depot medroxyprogesterone acetate (104mg/0.65mL): A systematic review

Title
The safety of subcutaneously administered depot medroxyprogesterone acetate (104mg/0.65mL): A systematic review
Authors
Keywords
Depot medroxyprogesterone, DMPA, Subcutaneous, Progestogen-only injectables, Safety
Journal
CONTRACEPTION
Volume 94, Issue 3, Pages 202-215
Publisher
Elsevier BV
Online
2016-02-10
DOI
10.1016/j.contraception.2016.02.003

Ask authors/readers for more resources

Reprint

Contact the author

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now